
Adelis buys Med Group from Terveysrahasto
Sweden’s Adelis Equity Partners has acquired a majority stake in Finnish healthcare services provider Med Group from healthcare financing fund Terveysrahasto and the company’s founders.
Following the management buyout, the two founders and the management team will retain a significant minority shareholding in the company.
Terveysrahasto owned 38% of the business before the transaction, making it the largest single owner.
Adelis's Rasmus Molander said the firm sees particular growth opportunities in the dental, homecare and personal assistance areas.
The former founder and CEO of Capio and Global Health Partner, Per Båtelson, will also invest in the company as part of the deal; he becomes a board member and adviser to Med Group's management.
Company
Founded in 2007, Med Group is a Finnish healthcare company providing ambulance, medical, oral healthcare, homecare and personal assistance services. Many of these are provided as a partner to Finland's public sector.
Based in Vantaa, near Helsinki, Med Group employs 800 people and expects to generate revenues of €50m this year.
People
Ramus Molander is part of Adelis's investment team, while Kustaa Piha is the CEO of Med Group.
Advisors
Equity – KPMG (Financial due diligence); Ditmar & Indrenius (Legal)
Vendor – Handelsbanken (Corporate finance); Deloitte (Financial due diligence); Borenius (Legal)
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater